Proclaim Dorsal Root Ganglion (DRG) System
ABBOTT MEDICAL · Decision date Dec 23, 2025
What did the FDA decide?
FDA records P150004/S092 as a supplement to PMA P150004, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 23, 2025.
FDA approval order statement
to implement quality control testing changes for the neuromodulation devices manufactured in Arecibo, Puerto Rico
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Neurology
- Decision date
- Dec 23, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P150004/S092
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- PMP
- Decision code
- OK30
- Decision date
- Dec 23, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Dorsal root ganglion stimulator for pain relief.
- Applicant
- Abbott Medical
- Product code
- PMP
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P150004. Subsequent supplements may change the device or its indications.
FDA decision timeline
P150004 · Original PMA
Axium Neurostimulator System
P150004/S087 · Related supplement
Proclaim DRG IPG
P150004/S089 · Related supplement
Proclaim Doral Root Ganglion (DRG) IPG
P150004/S091 · Related supplement
DRG Neurostimulation System
P150004/S088 · Related supplement
Proclaim DRG System
P150004/S090 · Related supplement
Dorsal Root Ganglion (DRG) Neurostimulation System
P150004/S092 received
Application receipt date recorded by FDA.
P150004/S092 · FDA decision
30-Day Notice
P150004/S085 · Related supplement
Proclaim Dorsal Root Ganglion (DRG) Neurostimulator System
P150004/S093 · Related supplement
Proclaim Doral Root Ganglion (DRG) IPG
P150004/S094 · Related supplement
Proclaim Dorsal Root Ganglion (DRG) IPG
P150004/S095 · Related supplement
Dorsal Root Ganglion (DRG) Implantable Pulse Generator (IPG)
P150004/S099 · Related supplement
Dorsal Root Ganglion (DRG) IPG
P150004/S100 · Related supplement
Proclaim DRG IPG
P150004/S101 · Related supplement
Dorsal Root Ganglion Stimulation (DRG) EPG
Timeline entries are records held by MedtechLedger for P150004. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150004
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 6901 Preston Rd., Plano, TX, 75024
Sources and methodology
- Original FDA record: P150004/S092
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





